
RXRX vs VIVS
$RXRX vs $VIVS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RXRX vs VIVS: the quick read
- ·RXRX is the larger company by market cap ($2.12B vs $3M).
- ·RXRX has been more active on our scanner (298 vs 16 alerts in 30 days).
- ·VIVS has the smaller float (14.8M vs 536.3M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·VIVS trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·RXRX draws far more of our scanner's attention, 298 unusual-volume alerts in 30 days against 16, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: RXRX is more than 805x the market cap of VIVS, so the same dollar of news moves VIVS far harder.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RXRX and VIVS on TheDesperateTrader.
- Is RXRX or VIVS the better stock?
- "Better" depends on your goal, and these two are not alike. RXRX is the larger company by market cap ($2.12B vs $3M). RXRX has been more active on our scanner (298 vs 16 alerts in 30 days). VIVS has the smaller float (14.8M vs 536.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RXRX and VIVS?
- The differences that matter: RXRX is roughly 805x the size of the other by market cap ($2.12B vs $3M); they trade at very different share prices ($3.94 vs $0.18); RXRX sits at 27% of its 52-week range against 0% for VIVS; our scanner flagged RXRX 298 times in the last 30 days against 16 for VIVS. Everything above is measured from the latest completed session and SEC filings.
- Which of RXRX and VIVS is more active right now?
- Right now RXRX is at about 1.3x its normal volume and VIVS is at about 1.1x, so RXRX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RXRX or VIVS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore RXRX and VIVS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.